Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DXCM – DexCom, Inc.

DXCM — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

4.83

Margin Of Safety %

-15

Put/Call OI Ratio

1.05

EPS Next Q Diff

0.16

EPS Last/This Y

0.45

EPS This/Next Y

0.47

Price

72.13

Target Price

82.28

Analyst Recom

1.47

Performance Q

-1.58

Upside

13.6%

Beta

1.43

Ticker: DXCM




21 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-24DXCM61.551.024.2889151
2026-04-27DXCM61.441.031.1587516
2026-04-28DXCM59.321.031.4988387
2026-04-29DXCM57.551.051.4790704
2026-04-30DXCM59.531.051.4092487
2026-05-01DXCM61.351.070.57103984
2026-05-04DXCM60.041.041.9996555
2026-05-05DXCM59.491.030.4896665
2026-05-06DXCM60.351.020.2998323
2026-05-07DXCM60.931.021.8198428
2026-05-08DXCM60.621.030.4799317
2026-05-11DXCM59.331.052.5197941
2026-05-12DXCM61.131.071.11100923
2026-05-13DXCM58.551.070.56102589
2026-05-14DXCM57.821.060.35103498
2026-05-15DXCM61.641.000.39106855
2026-05-18DXCM65.121.110.4390119
2026-05-19DXCM66.941.091.3592293
2026-05-20DXCM71.451.080.2493732
2026-05-21DXCM71.981.031.1096853
2026-05-22DXCM72.111.050.2597903
DateSymbolLatestP/C OIP/C VolTotal OI
21 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-24DXCM61.5647.2-51.72.49
2026-04-27DXCM61.4247.2-34.52.49
2026-04-28DXCM59.3047.2-69.62.49
2026-04-30DXCM59.5347.16.12.50
2026-05-01DXCM61.3447.125.52.50
2026-05-04DXCM60.0325.6-169.52.50
2026-05-05DXCM59.4926.6-155.72.57
2026-05-06DXCM60.3326.6-129.22.57
2026-05-07DXCM60.9126.4-129.52.57
2026-05-08DXCM60.6126.5-145.32.58
2026-05-11DXCM59.3626.5-163.12.58
2026-05-12DXCM61.1126.5-105.82.58
2026-05-13DXCM58.5426.5-187.72.58
2026-05-14DXCM57.8126.5-154.32.58
2026-05-15DXCM61.6526.5-64.82.58
2026-05-18DXCM65.1226.5-75.82.58
2026-05-19DXCM66.9326.5-108.42.58
2026-05-20DXCM71.4626.3-64.02.58
2026-05-21DXCM71.8826.3-132.92.58
2026-05-22DXCM72.1326.4-136.32.59
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-24DXCM0.11-2.103.89
2026-04-27DXCM0.08-1.934.02
2026-04-28DXCM0.08-1.934.02
2026-04-29DXCM0.08-1.934.02
2026-04-30DXCM0.08-1.934.02
2026-05-01DXCM0.08-1.934.02
2026-05-04DXCM0.08-1.734.02
2026-05-05DXCM0.08-1.734.02
2026-05-06DXCM0.08-1.734.02
2026-05-07DXCM0.08-1.734.02
2026-05-08DXCM0.08-1.734.02
2026-05-11DXCM-0.11-1.844.02
2026-05-12DXCM-0.11-1.844.85
2026-05-13DXCM-0.09-1.844.85
2026-05-14DXCM-0.09-1.844.85
2026-05-15DXCM-0.11-1.844.85
2026-05-18DXCM-0.07-1.414.83
2026-05-19DXCM-0.09-1.414.83
2026-05-20DXCM-0.11-1.414.83
2026-05-21DXCM-0.11-1.414.83
2026-05-22DXCM-0.11-1.414.83
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.51

Avg. EPS Est. Current Quarter

0.61

Avg. EPS Est. Next Quarter

0.67

Insider Transactions

-0.11

Institutional Transactions

-1.41

Beta

1.43

Average Sales Estimate Current Quarter

1290

Average Sales Estimate Next Quarter

1338

Fair Value

61.46

Quality Score

97

Growth Score

98

Sentiment Score

96

Actual DrawDown %

56.3

Max Drawdown 5-Year %

-66.3

Target Price

82.28

P/E

30.84

Forward P/E

23.49

PEG

1.15

P/S

5.77

P/B

9.41

P/Free Cash Flow

19.46

EPS

2.34

Average EPS Est. Cur. Y​

2.59

EPS Next Y. (Est.)

3.05

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

19.31

Relative Volume

1.27

Return on Equity vs Sector %

4.4

Return on Equity vs Industry %

19.6

EPS 1 7Days Diff

EPS 1 30Days Diff

0.09

EBIT Estimation

-136.3
DXCM Healthcare
$72.10
📉
Swing / Pullback
Buy the dip on strong trends
39 /100
WEAK
Trend
14/20
Pullback
8/25
Volume
1/15
Valuation
11/20
TP/AR
2/10
Options
3/10
RSI
70
Range 1M
95%
Sup Dist
2%
🚀
Momentum Growth
Ride accelerating trends
50 /100
WEAK
Momentum
15/25
Growth
21/30
Estimates
6/20
Inst/Vol
2/15
Options
6/10
EPS Yr
23.8%
EPS NY
18.6%
52W%
50.5%
💎
Long-Term Value
Quality companies, undervalued
67 /100
WATCH
🟡 HOLD +22.4% upside
Quality
30/30
Valuation
10/30
Growth
17/25
Stability
6/10
LT Trend
4/5
Upside
+22.4%
Quality
97
MoS
-15%
DexCom, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 11000
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
DXCM

Latest News

Caricamento notizie per DXCM
stock quote shares DXCM – DexCom, Inc. Stock Price stock today
news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DXCM – DexCom, Inc. yahoo finance google finance
stock history DXCM – DexCom, Inc. invest stock market
stock prices DXCM premarket after hours
ticker DXCM fair value insiders trading